Have analysts changed their opinion about the stock?
For more information, please visit: Wave Life Sciences Ltd. (NASDAQ:WVE) shareholders are likely a little disappointed as shares fell 8.9% to $5.41 in the week following the release of its latest quarterly results. Revenues were in line with expectations at $20 million, while statutory losses widened to $0.25 per share. Following the results release, analysts […]
